Nuvalent (NASDAQ:NUVL) Upgraded to Outperform by SVB Leerink

SVB Leerink upgraded shares of Nuvalent (NASDAQ:NUVL – Free Report) from a market perform rating to an outperform rating in a research note published on Monday, MarketBeat Ratings reports. SVB Leerink currently has $110.00 price target on the stock, up from their previous price target of $69.00. NUVL has been the subject of a number […]

Related Keywords

Leerink Partnrs , Robertw Baird , Matthew Shair , Nuvalent Inc , Metlife Investment Management , Jpmorgan Chase Co , York Mellon Corp , Blackrock Inc , Securities Exchange Commission , Free Report , Marketbeat Ratings , Moderate Buy , Get Free Report , Director Matthew Shair , Exchange Commission , Darlene Noci , New York Mellon Corp , Life Investment Management , Nuvalent Daily ,